Hermine Agis

8.4k total citations
123 papers, 3.2k citations indexed

About

Hermine Agis is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Hermine Agis has authored 123 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Hematology, 52 papers in Immunology and 40 papers in Molecular Biology. Recurrent topics in Hermine Agis's work include Mast cells and histamine (39 papers), Multiple Myeloma Research and Treatments (30 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (23 papers). Hermine Agis is often cited by papers focused on Mast cells and histamine (39 papers), Multiple Myeloma Research and Treatments (30 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (23 papers). Hermine Agis collaborates with scholars based in Austria, Germany and United States. Hermine Agis's co-authors include Peter Valent, Wolfgang R. Sperr, Klaus Lechner, Christian Sillaber, Martin Willheim, Klaus Geißler, Wolfgang Füreder, Herbert Strobl, Hans Bankl and Peter Bettelheim and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hermine Agis

118 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hermine Agis Austria	32	1.9k	875	824	722	592	123	3.2k
Yoshio Kanayama Japan	25	1.8k 1.0×	865 1.0×	946 1.1×	482 0.7×	464 0.8×	78	3.1k
Alexander W. Hauswirth Austria	26	928 0.5×	488 0.6×	353 0.4×	508 0.7×	376 0.6×	64	2.0k
Yojiro Arinobu Japan	26	1.5k 0.8×	516 0.6×	781 0.9×	231 0.3×	448 0.8×	77	2.8k
Hans‐Peter Horny Germany	42	3.3k 1.8×	1.2k 1.3×	885 1.1×	890 1.2×	2.4k 4.0×	147	5.5k
Wayel H. Abdulahad Netherlands	39	1.9k 1.0×	194 0.2×	667 0.8×	438 0.6×	1.3k 2.3×	128	4.3k
Koichiro Ohmura Japan	35	1.9k 1.0×	485 0.6×	872 1.1×	230 0.3×	1.8k 3.0×	170	4.3k
J D Griffin United States	32	1.5k 0.8×	945 1.1×	1.3k 1.5×	420 0.6×	168 0.3×	47	3.7k
Alan H. Lazarus Canada	35	1.8k 1.0×	2.2k 2.5×	625 0.8×	323 0.4×	171 0.3×	117	4.3k
Christopher F. Mojcik United States	21	2.2k 1.2×	906 1.0×	304 0.4×	186 0.3×	441 0.7×	35	3.6k
J Guichard France	35	884 0.5×	2.5k 2.9×	916 1.1×	453 0.6×	213 0.4×	77	4.0k

Countries citing papers authored by Hermine Agis

Since Specialization

Citations

This map shows the geographic impact of Hermine Agis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hermine Agis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hermine Agis more than expected).

Fields of papers citing papers by Hermine Agis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hermine Agis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hermine Agis. The network helps show where Hermine Agis may publish in the future.

Co-authorship network of co-authors of Hermine Agis

This figure shows the co-authorship network connecting the top 25 collaborators of Hermine Agis. A scholar is included among the top collaborators of Hermine Agis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hermine Agis. Hermine Agis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jeryczynski, Georg, et al.. (2025). Optimizing Belantamab Mafodotin in Relapsed or Refractory Multiple Myeloma: Impact of Dose Modifications on Adverse Events and Hematologic Response in a Real-World Retrospective Study. Cancers. 17(14). 2398–2398.

Duca, Franz, Christina Kronberger, René Rettl, et al.. (2025). Serial extracellular volume quantification using cardiac magnetic resonance imaging in transthyretin amyloidosis patients treated with tafamidis. European Radiology. 36(1). 172–181.

Agis, Hermine, et al.. (2023). ASH highlights 2022—multiple myeloma. memo - Magazine of European Medical Oncology. 16(3). 160–164. 1 indexed citations

Agis, Hermine, et al.. (2023). Teduglutide in amyloidosis‐associated intestinal failure. SHILAP Revista de lepidopterología. 11(8). e7653–e7653. 2 indexed citations

Heinemann, Tim, Christoph Kornauth, Yannik Severin, et al.. (2022). Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision Medicine. Blood Cancer Discovery. 3(6). 502–515. 11 indexed citations

Kammerlander, Andreas A., Franz Duca, Christian Nitsche, et al.. (2021). Convolutional Neural Networks for Fully Automated Diagnosis of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging. Journal of Personalized Medicine. 11(12). 1268–1268. 21 indexed citations

Dachs, Theresa-Marie, Matthias Koschutnik, Daniel Dalos, et al.. (2020). Machine Learning Enables Prediction of Cardiac Amyloidosis by Routine Laboratory Parameters: A Proof-of-Concept Study. Journal of Clinical Medicine. 9(5). 1334–1334. 19 indexed citations

Demyanets, Svitlana, Alexandra Kaider, Ingrid Simonitsch‐Klupp, et al.. (2020). Biological properties of bone marrow plasma cells influence their recovery in aspirate specimens: impact on classification of plasma cell disorders and potential bias to evaluation of treatment response. Annals of Hematology. 99(11). 2599–2609. 4 indexed citations

Duca, Franz, Stefan Aschauer, Caroline Zotter‐Tufaro, et al.. (2019). Riociguat for the treatment of transthyretin cardiac amyloidosis: data from a named patient use program in Austria. Pulmonary Circulation. 9(4). 1–9. 1 indexed citations

10.

Krauth, Maria-T., Stefan Florian, Alexandra Böhm, et al.. (2006). Immunological Characterization and Antibacterial Function of Persisting Granulocytes in Leukemic Patients Receiving Pulse Cytosine Arabinoside-Consolidation Chemotherapy on Days 1, 3, and 5. The Journal of Immunology. 176(3). 1759–1768. 3 indexed citations

11.

Krauth, Maria‐Theresa, Alexandra Böhm, Hermine Agis, et al.. (2006). Effects of the CD33-targeted drug gemtuzumab ozogamicin (Mylotarg) on growth and mediator secretion in human mast cells and blood basophils. Experimental Hematology. 35(1). 108–116. 31 indexed citations

12.

Agis, Hermine, Christine Mannhalter, Wolfgang R. Sperr, et al.. (2004). Detection of Trisomy 8 in Donor-Derived Ph⁻Cells in a Patient with Ph⁺Chronic Myeloid Leukemia Successfully Treated with Imatinib (STI571) in Relapse after Allogeneic Transplantation. Leukemia & lymphoma. 45(7). 1453–1458. 6 indexed citations

13.

Baghestanian, Mehrdad, John-Hendrik Jordan, Hans P. Kiener, et al.. (2002). Activation of Human Mast Cells through Stem Cell Factor Receptor (KIT) Is Associated with Expression of bcl-2. International Archives of Allergy and Immunology. 129(3). 228–236. 27 indexed citations

14.

Sperr, Wolfgang R., Hermine Agis, H. Semper, et al.. (1997). Inhibition of Allergen-Induced Histamine Release from Human Basophils by Cyclosporine A and FK-506. International Archives of Allergy and Immunology. 114(1). 68–73. 19 indexed citations

15.

Agis, Hermine, Wolfgang Füreder, Hans Bankl, et al.. (1996). Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology. 87(4). 535–543. 117 indexed citations

16.

Agis, Hermine, Waltraud J. Beil, Hans Bankl, et al.. (1996). Mast Cell-Lineage Versus Basophil Lineage Involvement in Myeloproliferative and Myelodysplastic Syndromes: Diagnostic Role of Cell-Immunopheno typing. Leukemia & lymphoma. 22(3-4). 187–204. 34 indexed citations

17.

Willheim, Martin, Paolo Silacci, Alois Gessl, et al.. (1995). Tumor necrosis factor‐α induction of major histocompatibility complex class. II antigen expression is inhibited by interferon‐γ in a monocytic cell line. European Journal of Immunology. 25(11). 3202–3206. 4 indexed citations

18.

Fritsch, G., Margit Stimpfl, P Buchinger, et al.. (1994). Does Cord Blood Contain Enough Progenitor Cells for Transplantation?. Journal of Hematotherapy. 3(4). 291–298. 14 indexed citations

19.

Gessl, Alois, Martin Willheim, Andreas Spittler, et al.. (1994). Influence of Tumour Necrosis Factor‐α on the Expression of Fc IgG and IgA Receptors, and Other Markers by Cultured Human Blood Monocytes and U937 Cells. Scandinavian Journal of Immunology. 39(2). 151–156. 31 indexed citations

20.

Agis, Hermine, Martin Willheim, Wolfgang R. Sperr, et al.. (1993). Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c- kit +, CD34+, Ly-, CD14-, CD17-, colony-forming cell.. The Journal of Immunology. 151(8). 4221–4227. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact